A Japanese case of ovarian mucinous adenocarcinoma with germline double variants of MSH2 and BRCA2
- PMID: 37420004
- DOI: 10.1038/s10038-023-01178-6
A Japanese case of ovarian mucinous adenocarcinoma with germline double variants of MSH2 and BRCA2
Abstract
Germline double heterozygosity (GDH) is rarely reported in cases of inherited cancer syndromes, and GDH of a mismatch repair gene and BRCA has never been reported in Japan. Nonetheless, the current report demonstrates a case of ovarian mucinous adenocarcinoma with initiated Lynch syndrome (LS)-related surveillance because of a known germline MSH2 variant. Six and a half years after oophorectomy, multiple tumors developed in the patient's lungs, bones, and lymph nodes, and histology results confirmed mucinous adenocarcinoma. Systemic chemotherapy including an anti-PD-L1 antibody was effective for >1 year, but brain metastases developed. Pathology of the brain tumors showed mucinous adenocarcinoma without expression of MSH2 and MSH6, while multi-gene panel testing demonstrated not only high microsatellite instability and a high tumor mutation burden, but also germline BRCA2 variants. Further, germline testing in relatives confirmed both variants were from the paternal line, from which many LS-related cancers develop, but not BRCA-related cancer.
© 2023. The Author(s), under exclusive licence to The Japan Society of Human Genetics.
References
-
- Japanese organization of Hereditary Breast and Ovarian Cancer (JOHBOC). Guidelines for Diagnosis and Treatment of Hereditary Breast and Ovarian Cancer. 2021, https://johboc.jp/guidebook_2021/ (in Japanese).
LinkOut - more resources
Research Materials
Miscellaneous